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The Editorial on the Research Topic
Mitochondria in Skeletal Muscle Health, Aging and Diseases
Mitochondria are fascinating organelles regulating many critical cellular processes for skeletal
muscle physiology. Indeed, they play central roles in muscle cell metabolism, energy
supply, the regulation of energy-sensitive signaling pathways, reactive oxygen species (ROS)
production/signaling, calcium homeostasis and the regulation of apoptosis (Brookes et al., 2004).
Given these multifaceted roles of mitochondria in fundamental aspects of skeletal muscle cell
physiology, it is not surprising that mitochondrial dysfunction has been implicated in a large
number of adverse conditions affecting skeletal muscle health. This includes for instance the aging-
related loss of muscle mass and function (Dirks and Leeuwenburgh, 2004; Short et al., 2005; Chabi
et al., 2008; Gouspillou et al., 2010, 2014a,b; Picard et al., 2010; Hepple, 2014), disuse-induced
muscle atrophy (Min et al., 2011), ventilator-induced diaphragmatic dysfunction (Picard et al.,
2015), Duchenne and collagen muscular dystrophies (Godin et al., 2012; Bernardi and Bonaldo,
2013), long-term muscle dysfunction induced by chemotherapy treatment (Gouspillou et al., 2015;
Power et al., 2016), and the development of insulin resistance (Goodpaster, 2013).
While the importance of normal mitochondrial function is well recognized for muscle
physiology, there are important aspects of mitochondrial biology that are still poorly
understood/investigated in the highly specialized muscle tissue. These include mitochondrial
dynamics (fusion and fission processes), morphology and processes involved in mitochondrial
quality control (mitophagy). Defining the mechanisms regulating these different aspects of
mitochondrial biology, their importance for muscle physiology, as well as the interrelations existing
between mitochondrial function, morphology, dynamics and mitophagy will be critical to further
increase our understanding of the role played by mitochondria in skeletal muscle physiology
and pathophysiology. The aim of the present research topic was therefore to bring together key
experiments, advances, knowledge and new findings related to all aspects of mitochondrial biology
in healthy and/or diseased muscle cells.
The accurate assessment of mitochondrial function is of crucial importance to dissect the role
played by mitochondrial dysfunction in pathologies affecting skeletal muscles. It is also essential for
the clear identification of mitochondrial adaptations to various interventions, such as nutritional
or physical activity interventions. In the present research topic, Conley et al. provide a promising
approach to assess mitochondrial oxidative phosphorylation in vivo by monitoring changes in
mitochondrial NAD(P)H using 31P NMR spectroscopy. In their study, Conley et al. show that
a unique resonance (−11.05 ppm) in the in vivo 31P spectrum provides a natural indicator of
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mitochondrial oxidation that is sensitive to the increase in
mitochondrial phosphorylation rate induced by exercise training
in elderly individuals.
One of the commonly used methods to assess mitochondrial
function in vitro in skeletal muscle is the preparation of
permeabilized myofibers (Kuznetsov et al., 2008). To be applied
in humans, this technique requires biopsies to collect muscle
samples. While the Bergstrom biopsy technique (Bergstrom,
1975) is the gold standard to collect skeletal muscle samples,
a growing interest now surrounds microbiospsies due to their
lower level of invasiveness (Hayot et al., 2005). However, no
previous in-depth validation of this method for the assessment of
mitochondrial function in permeabilized myofibers and for the
assessment of muscle phenotype had been performed to date.
Hughes et al. therefore compared mitochondrial bioenergetics
in muscle sample obtained through Bergstrom biopsies vs.
microbiopsies. They reveal that microbiopsies can provide a
reliable assessment of mitochondrial bioenergetics only when
assay conditions are supplemented with the myosin ATPase
inhibitor Blebistatin. However, the authors highlight that caution
should be taken when assessing muscle fiber type composition
using the microbiopsy approach, since significant differences in
fiber type proportion were observed between the two approaches
(Hughes et al.).
Oxidative stress is thought to play an important role in
skeletal muscle dysfunction and atrophy seen in aging, disuse,
and many skeletal muscle pathologies (Powers et al., 2012;
Johnson et al., 2013). Because they are considered as one of
the main sources of ROS production, mitochondria are a key
focus in the field of oxidative stress. While reactive oxygen
and nitrogen species were initially only seen as detrimental for
muscle cells, it is now recognized that these reactive species are
essential for normal skeletal muscle physiology (Sohal and Orr,
2012), mainly through the reversible redox post-translational
modifications they can induce. The ability to accurately quantify
reversible redox post-translational modifications is therefore
critical to investigate the mechanisms by which mitochondrial
oxidative stress contributes to skeletal muscle dysfunction in
diseases. In their article, Kramer et al. provide a detailed review
of the available literature on reversible redox post-translational
modifications and mitochondrial and skeletal muscle function.
They then provide critical review on current approaches to assess
reversible redox post-translational modifications (Kramer et al.).
Several studies have implicated altered kinetic properties
of the adenine nucleotide translocator (ANT) in the aging-
related impairment in mitochondrial energetics in skeletal
muscle cells (Yan and Sohal, 1998; Gouspillou et al., 2014b).
In the present research topic, Diolez et al. formulate the
interesting hypothesis that these alterations in ANT could
represent a protective mechanism to limit ROS production
in aged muscle mitochondria while moderately disrupting
mitochondrial energetics. Considering the importance of ROS as
therapeutic targets, this hypothetical mechanism deserves further
study.
The present research topic also provides readers with
fundamental advancement in our understanding of the
regulation of mitochondrial function in skeletal muscle cells.
Indeed, in an elegant study, Lark et al. provide evidence that
Protein Kinase A (PKA) can regulate mitochondrial energetics
and H2O2 emission. Using PKA inhibitors and various
mitochondrial substrates, they show that this regulation occurs
at the level of Complex I. Finally, they provide new insights on
how mitochondrial cyclic adenosine monophosphate (cAMP)
production, cAMP being a positive regulator of PKA, is regulated
(Lark et al.).
Understanding how nutrition modulates mitochondrial
biology in muscle cells is of tremendous importance in the
field of medicine. For instance, mitochondrial dysfunction
has been suggested to be causally involved in obesity-induced
insulin resistance and in the pathophysiology of type II diabetes
(Goodpaster, 2013). Precisely defining how skeletal muscle
mitochondria respond to obesogenic diet feeding is therefore
of critical importance. In the present research topic, Putti et al.
provide readers with a mini-review focused on the impacts of
different dietary fat sources on mitochondrial bioenergetics,
morphology and dynamics in skeletal muscle cells in the context
of insulin-resistance. They also highlight the pressing need for
mechanistic studies to confirm in vivo the relationship between
mitochondrial morphology and dynamics and the development
of insulin-resistance (Putti et al.).
Besides being of particular interest for the field of medicine,
defining the impact of nutrition on mitochondrial biology is also
an important research topic in the field of exercise physiology.
The present research topic features two important review articles
in this field. The first one, written by Craig et al. critically reviews
the available literature on the utilization of small nutrients, such
as caffeine, green tea extracts, polyphenols and amino-acids
to enhance the impact of exercise training on mitochondrial
biogenesis. They also provide recommendations and guidance for
future studies that are required to explore the efficacy of these
nutrients in humans, as well as the exercise setting in which they
may prove beneficial (Craig et al.). The second review, written
by Affourtit et al., first provides a state-of-the-art review of the
available literature on the beneficial effects of dietary nitrate
on human performance. Affourtit et al. then critically review
the available experimental data in relation to the underlying
mechanisms, with a particular emphasis on the impact of nitrate
on mitochondrial bioenergetics.
It is now well established that low birth weight is associated
with an increase in the risk of developing disease in later life such
as coronary heart disease, diabetes, hypertension and stroke (see
de Boo and Harding, 2006; Gluckman et al., 2008 for detailed
reviews). Maternal undernutrition ranks as one of the most
important causes that can lead to low birth weight (de Boo
and Harding, 2006). In the present research topic, Beauchamp
and Harper review the available evidence indicating that
in utero undernutrition results in a metabolic reprogramming
in both cardiac and skeletal muscles, characterized for instance
by a reduction in mitochondrial content and respiration in
the offspring. They also provide insights into the underlying
mechanisms and provide a rationale linking the metabolic
alterations resulting from in utero undernutrition to the
increased risk of developing metabolic diseases (Beauchamp and
Harper).
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As mentioned earlier, mitochondrial dysfunction has been
implicated in many conditions associated with muscle atrophy,
including aging, cancer cachexia, and disuse-induced muscle
atrophy (Dirks and Leeuwenburgh, 2004; Short et al., 2005;
Chabi et al., 2008; Gouspillou et al., 2010, 2014a,b; Picard
et al., 2010, 2015; Min et al., 2011; Hepple, 2014; Argilés
et al., 2015). While the field to date has mainly focused on
mitochondrial function (i.e., energetics, ROS production and
mitochondrial mediated apoptosis), a growing interest now
surroundsmechanisms involved inmitochondrial quality control
(i.e., mechanisms responsible for the degradation of damaged
/ dysfunctional mitochondria). In the present research topic,
Romanello and Sandri provide readers with a thorough and
critical review on the current knowledge linking mitochondrial
function, dynamics and quality control in the regulation of
muscle mass. They also highlight several research avenues and
challenges that will undoubtedly stimulate the field (Romanello
and Sandri).
In the present research topic, Ryan et al. contributed a
very interesting review paper focused on skeletal muscle and
endothelial cell mitochondria in the setting of Critical Limb
Ischemia. The latter is the most severe clinical presentation of
peripheral arterial disease and manifests as chronic ischaemic
“rest pain” and/or ischaemic skin lesions (Minar, 2009).
Unfortunately, there is no effective way to treat the muscle
myopathies caused by this disease. In their review, Ryan et al. first
highlight the importance of skeletal muscle in the manifestation
of Critical Limb Ischemia, and then provide a strong and exciting
rationale for a role for endothelial cell and skeletal muscle
mitochondria in the patient outcomes. As such, they propose
that limb muscle and endothelial cell mitochondria should be
considered as targets for novel therapeutic intervention (Ryan
et al.).
Skeletal muscles have an impressive capacity to adapt to
mechanical and physiological challenges by changing their
phenotype in terms of size, fiber type, capillarization levels and
aerobic capacity. Although skeletal muscle plasticity has been
the focus of intense research effort, the molecular mechanisms
underlying muscle plasticity are still incompletely understood.
Since the seminal paper published by Spiegleman’s group in
2002 (Lin et al., 2002), in which PGC-1α over-expression was
shown to result in an increase in the proportion of slow-oxidative
fibers, PGC-1α has attracted sustained attention. In the present
research topic, Kupr and Handschin discuss recent advances
in our understanding of how PGC-1α regulates skeletal muscle
cell plasticity in health and disease. They also highlight further
avenues of research to fully decrypt how PGC-1α influences
muscle plasticity in health and disease (Kupr and Handschin).
Although often overlooked, our endocrine system exerts an
important control on the regulation of mitochondrial mass and
function in skeletal muscle cells, especially through thyroid
hormones (Salvatore et al., 2014). Amongst thyroid hormones
exerting control on mitochondrial biology in skeletal muscle
cells, 3,5,3′-Triiodo-L-thyronine (T3) has been extensively
studied (Salvatore et al., 2014). In the present research topic,
Lumbardi et al. review the experimental evidence indicating
that 3,5-diiodo-L-thyronine (T2), and emerging iodothyronines
also impact mitochondrial metabolism in skeletal muscle cells
(Lombardi et al.). These novel aspects of thyroid physiology
reviewed in Lombardi et al. open new perspectives for
understanding the involvement of skeletal muscle mitochondria
in systemic consequences of hypo- and hyper-thyroidism.
Because of the diversity and the quality of the articles compiled
herein, we feel the present research topic was a success. We
hope that it will not only provide readers with new insights
and viewpoints on the role played by mitochondria in skeletal
muscle health, aging and diseases, but will also serve as a platform
to stimulate new ideas, experiments and research projects for
further advances in the field.
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